Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Michael Fowler, Stanford University
ClinicalTrials.gov Identifier:
NCT00657280
First received: April 9, 2008
Last updated: December 23, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)